Free provider profile
AMIR ETESAM
Registry record
Source: CMS NPPES registry, updated continuously. This record was last updated 2025-03-10.
6000 EXECUTIVE BLVD STE 101, NORTH BETHESDA, MD, 20852
240-599-1001
Single practice location
Enumerated 2018-08-19
- — Registration is active in NPPES.
- — Individual clinician record — reachable, but usually not the buyer.
- — Practice phone number is published.
- — Full street address on file for route planning.
- — Record updated within the last three years.
Medicare Part D prescribing
Source: CMS Medicare Part D Prescribers by Provider, most recent public year.
Part D claims
501
Medicare patients
63
Part D drug cost
$310,390
Brand-name share
31.3%
of this prescriber's Part D claims
| Drug | Claims | Medicare cost |
|---|---|---|
| Spravato (Esketamine Hcl) | 117 | $271,662 |
| Vyvanse (Lisdexamfetamine Dimesylate) | 15 | $8,641 |
| Duloxetine Hcl (Duloxetine Hcl) | 38 | $1,279 |
| Bupropion Xl (Bupropion Hcl) | 14 | $494 |
| Mirtazapine (Mirtazapine) | 30 | $462 |
| Lamotrigine (Lamotrigine) | 23 | $385 |
| Quetiapine Fumarate (Quetiapine Fumarate) | 27 | $295 |
| Trazodone Hcl (Trazodone Hcl) | 32 | $289 |
Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.
Spravato (esketamine) Medicare billing
Source: CMS Medicare Part B fee-for-service, HCPCS G2082/G2083.
Full Spravato label-compliance detail — sessions per patient against the FDA label, risk flags and year-over-year trend.
- Registry data comes straight from CMS NPPES, which lists registration, not activity — a listed practice may have moved or closed.
- Part D covers Medicare prescription drug enrollees only. Commercial, Medicaid and cash-pay prescribing is not included, so these figures are a floor on real volume, not the whole picture.
- CMS publishes the Part D file annually, roughly two years behind the prescribing year. Drugs with 10 or fewer claims are suppressed.
